Mika Derynck
Directeur/Bestuurslid bij ENLIVEN THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Mika Kakefuda Derynck is currently working as a Director and Independent Director at Enliven Therapeutics, Inc. and as the Chief Medical Officer at Amunix Pharmaceuticals, Inc. She completed her undergraduate degree at Boston University and her doctorate at Boston University School of Medicine.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
08-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Mika Derynck
Bedrijven | Functie | Begin |
---|---|---|
ENLIVEN THERAPEUTICS, INC. | Directeur/Bestuurslid | 23-02-2023 |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | 19-01-2022 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Mika Derynck
Boston University | Undergraduate Degree |
Boston University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ENLIVEN THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |